T

TransMedics Group
D

TMDX

76.040
USD
-3.29
(-4.15%)
Market Closed
Volume
97,942
EPS
1
Div Yield
-
P/E
82
Market Cap
2,552,017,753
Related Instruments
    C
    CDNA
    -0.400
    (-1.86%)
    21.160 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    M
    MGTX
    -0.18000
    (-2.71%)
    6.47000 USD
    Q
    QURE
    -0.55000
    (-8.14%)
    6.21000 USD
    R
    RGNX
    -1.51500
    (-13.60%)
    9.62500 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    V
    VCEL
    -0.240
    (-0.46%)
    52.510 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    More
News

Title: TransMedics Group

Sector: Healthcare
Industry: Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.